The decision-making process and criteria in selecting candidate drugs for progeria clinical trials

    loading  Checking for direct PDF access through Ovid


Hutchinson–Gilford progeria syndrome (progeria) is an extremely rare premature aging disease with a population prevalence of 1 in 20 million. Nevertheless, propelled by the discovery of a causal mutation in the lamin A/C gene (LMNA) (De Sandre-Giovannoliet al,2003; Erikssonet al,2003) and strong patient advocacy (Gordon & Gordon,2014), progeria has rapidly become a vibrant field of study, attracting a wide range of researchers from basic cell biologists to clinicians.

Related Topics

    loading  Loading Related Articles